Curanex completes manufacturing milestones for Phyto-N drug candidate May 14, 2026 08:55AM
Curanex reports patient cases for cancer cachexia candidate Apr 8, 2026 07:47AM
Curanex shares patient case study for cancer cachexia treatment Apr 6, 2026 09:17AM
Curanex adds cancer cachexia to drug development pipeline Apr 2, 2026 08:07AM
Curanex completes GMP pilot for botanical drug candidate Phyto-N Feb 25, 2026 08:03AM


Jul 18, 2025 05:01PM Curanex Pharmaceuticals (CURX) Files for 3.75M Share IPO at $4-$6/sh